Leukemia and Lymphoma Research
E303120
Leukemia and Lymphoma Research is a UK-based medical research charity dedicated to improving the diagnosis, treatment, and prevention of blood cancers such as leukemia and lymphoma.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Leukemia and Lymphoma Research canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T2851011 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
Target entity: Leukemia and Lymphoma Research Context triple: [Prince Edward, Duke of Kent, patronOf, Leukemia and Lymphoma Research]
-
A.
Blood Cancer Discovery
Blood Cancer Discovery is a peer-reviewed scientific journal focusing on research and advances in the biology, diagnosis, and treatment of blood cancers.
-
B.
Children’s Cancer Research Foundation
The Children’s Cancer Research Foundation was the original name of what is now the Dana-Farber Cancer Institute, a leading U.S. center for cancer treatment and research.
-
C.
Center for Cancer Research
The Center for Cancer Research is the intramural research arm of the U.S. National Cancer Institute, conducting basic, translational, and clinical studies to advance cancer prevention, diagnosis, and treatment.
-
D.
American Association for Cancer Research
The American Association for Cancer Research is a leading professional organization dedicated to advancing cancer research, prevention, diagnosis, and treatment through scientific collaboration and dissemination of findings.
-
E.
Division of Cancer Treatment and Diagnosis
The Division of Cancer Treatment and Diagnosis is a branch of the National Cancer Institute that supports the development, evaluation, and clinical testing of new cancer therapies and diagnostic tools.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Target entity: Leukemia and Lymphoma Research Target entity description: Leukemia and Lymphoma Research is a UK-based medical research charity dedicated to improving the diagnosis, treatment, and prevention of blood cancers such as leukemia and lymphoma.
-
A.
Blood Cancer Discovery
Blood Cancer Discovery is a peer-reviewed scientific journal focusing on research and advances in the biology, diagnosis, and treatment of blood cancers.
-
B.
Children’s Cancer Research Foundation
The Children’s Cancer Research Foundation was the original name of what is now the Dana-Farber Cancer Institute, a leading U.S. center for cancer treatment and research.
-
C.
Center for Cancer Research
The Center for Cancer Research is the intramural research arm of the U.S. National Cancer Institute, conducting basic, translational, and clinical studies to advance cancer prevention, diagnosis, and treatment.
-
D.
American Association for Cancer Research
The American Association for Cancer Research is a leading professional organization dedicated to advancing cancer research, prevention, diagnosis, and treatment through scientific collaboration and dissemination of findings.
-
E.
Division of Cancer Treatment and Diagnosis
The Division of Cancer Treatment and Diagnosis is a branch of the National Cancer Institute that supports the development, evaluation, and clinical testing of new cancer therapies and diagnostic tools.
- F. None of above. chosen
Statements (47)
| Predicate | Object |
|---|---|
| instanceOf |
charitable organization
ⓘ
health charity ⓘ medical research charity ⓘ non-profit organization ⓘ |
| aimsTo |
improve quality of life for blood cancer patients
ⓘ
increase survival rates for blood cancers ⓘ raise awareness of blood cancers ⓘ |
| basedIn |
United Kingdom
ⓘ
surface form:
UK
|
| beneficiary | people affected by blood cancer ⓘ |
| country | United Kingdom ⓘ |
| fieldOfWork |
blood cancer research
ⓘ
cancer research ⓘ hematology ⓘ medical research ⓘ oncology ⓘ |
| focusArea |
early diagnosis of blood cancers
ⓘ
new treatments for blood cancers ⓘ patient information and support ⓘ prevention strategies for blood cancers ⓘ |
| focusesOn |
leukemia
ⓘ
lymphoma ⓘ myeloma ⓘ other blood cancers ⓘ |
| funds |
blood cancer research projects
ⓘ
clinical research fellowships ⓘ laboratory-based research ⓘ |
| headquartersLocation | United Kingdom ⓘ |
| languageOfWork | English ⓘ |
| mission |
fund research into blood cancers
ⓘ
improve diagnosis of blood cancers ⓘ improve prevention of blood cancers ⓘ improve treatment of blood cancers ⓘ support patients with blood cancer ⓘ |
| operatesIn | United Kingdom ⓘ |
| researchArea |
basic science of blood cancers
ⓘ
clinical trials in hematological malignancies ⓘ diagnosis of blood cancers ⓘ prevention of blood cancers ⓘ translational blood cancer research ⓘ treatment of blood cancers ⓘ |
| sector |
charity sector
ⓘ
healthcare sector ⓘ |
| supports |
families of blood cancer patients
ⓘ
patients with leukemia ⓘ patients with lymphoma ⓘ patients with myeloma ⓘ |
| typeOfNonProfit | research funding charity ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Subject: Leukemia and Lymphoma Research Description of subject: Leukemia and Lymphoma Research is a UK-based medical research charity dedicated to improving the diagnosis, treatment, and prevention of blood cancers such as leukemia and lymphoma.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.